Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Patent
1997-04-01
2000-06-13
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
514679, 514731, 514732, 568325, 568328, 568731, 568734, A61K 3112, A61K 3105, C07C 49105, C07C 3912
Patent
active
06075057&
ABSTRACT:
Optically pure enantiomers of avarol are obtained. The enantiomers of avarol are demonstrated to be highly effective inhibitors of .alpha.-glucosidase and .alpha.-mannosidase. Other enzymes assayed were not inhibited by these optically pure compounds. Inhibition of these two enzymes is useful for a variety of assays and probes, and offers particular utility in the treatment of retroviral infection-associated syndromes, such as AIDS.
REFERENCES:
patent: 4939177 (1990-07-01), Muller
patent: 4946869 (1990-08-01), Muller et al.
patent: 5026732 (1991-06-01), Muller
patent: 5204367 (1993-04-01), Wright et al.
Hecht Sidney M.
Locke Edward
Lambkin Deborah C.
The University of Virginia Patent Foundation
LandOfFree
Inhibition of carbohydrates metabolism by quinone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of carbohydrates metabolism by quinone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of carbohydrates metabolism by quinone compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2069077